Palantir Bioceuticals Inc (IFAN)

Currency in USD
0.000
0.000(0.00%)
Delayed Data·
IFAN Scorecard
Full Analysis
Stock has taken a big hit over the last week
IFAN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0000.000
52 wk Range
0.0000.001
Key Statistics
Prev. Close
-
Open
-
Day's Range
-
52 wk Range
0-0.001
Volume
-
Average Volume (3m)
2.4K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IFAN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Palantir Bioceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Palantir Bioceuticals Inc Company Profile

IFAN Financial, Inc., together with its subsidiaries, designs, develops, and distributes software to enable mobile payments. Its products include the ability to use a debit card and corresponding PIN number while purchasing online on a mobile phone, tablet, or computer, as well as peer-to-peer cash transfers. It has a portfolio of solutions, including mobile optimized ‘white label’ solutions with the ability to facilitate on demand payments, autopay, proximity payments and marketing, and a proprietary linked debit cards. The company’s ‘white label’ enterprise solutions offer mobile banking products and mobile commerce products, as well as white label mobile wallet and payment solutions. It also provides prepaid card programs for businesses and consumers; and traditional financial services for merchants separate from the Platform or using select features from it. The company was formerly known as Infantly Available, Inc. and changed its name to IFAN Financial, Inc. in September 2014. IFAN Financial, Inc. was founded in 2010 and is based in San Diego, California.

Employees
4

Compare IFAN to Peers and Sector

Metrics to compare
IFAN
Peers
Sector
Relationship
P/E Ratio
0.0x−8.3x11.8x
PEG Ratio
0.000.070.01
Price/Book
0.0x2.4x2.4x
Price / LTM Sales
0.0x6.3x2.2x
Upside (Analyst Target)
0.0%41.4%20.0%
Fair Value Upside
Unlock1.8%5.7%Unlock

Earnings

Latest Release
Nov 27, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

IFAN Income Statement

FAQ

What Stock Exchange Does Palantir Bioceuticals Trade On?

Palantir Bioceuticals is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Palantir Bioceuticals?

The stock symbol for Palantir Bioceuticals is "IFAN."

What Is the Palantir Bioceuticals Market Cap?

As of today, Palantir Bioceuticals market cap is 121.33K.

What Is Palantir Bioceuticals's Earnings Per Share (TTM)?

The Palantir Bioceuticals EPS (TTM) is -0.03.

From a Technical Analysis Perspective, Is IFAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Palantir Bioceuticals Stock Split?

Palantir Bioceuticals has split 1 times.

How Many Employees Does Palantir Bioceuticals Have?

Palantir Bioceuticals has 4 employees.

What is the current trading status of Palantir Bioceuticals (IFAN)?

As of 05 Aug 2025, Palantir Bioceuticals (IFAN) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.